Cargando…
Smart pH-responsive nanomedicines for disease therapy
BACKGROUND: Currently nanomedicines are the focus of attention from researchers and clinicians because of the successes of lipid-nanoparticles-based COVID-19 vaccines. Nanoparticles improve existing treatments by providing a number of advantages including protection of cargo molecules from external...
Autores principales: | Shinn, Jongyoon, Kwon, Nuri, Lee, Seon Ah, Lee, Yonghyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083479/ https://www.ncbi.nlm.nih.gov/pubmed/35573320 http://dx.doi.org/10.1007/s40005-022-00573-z |
Ejemplares similares
-
Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
por: Shinn, Jongyoon, et al.
Publicado: (2022) -
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
por: Lee, Yonghyun, et al.
Publicado: (2023) -
Smart nanomedicine agents for cancer, triggered by pH, glutathione, H(2)O(2), or H(2)S
por: Li, Yaping, et al.
Publicado: (2019) -
Recent Development of pH-Responsive Polymers for Cancer Nanomedicine
por: Tang, Houliang, et al.
Publicado: (2018) -
Engineering the pH-Sensitivity of the Graphene and Carbon Nanotube Based Nanomedicines in Smart Cancer Therapy by Grafting Trimetyl Chitosan
por: Khoshoei, Azadeh, et al.
Publicado: (2020)